Editas Medicine, Inc.EDITNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P97
Near historical high
vs 2Y Ago
1.3x
Solid growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 77.62% |
| Q3 2025 | 52.82% |
| Q2 2025 | 30.03% |
| Q1 2025 | -67.61% |
| Q4 2024 | 26.95% |
| Q3 2024 | 8.08% |
| Q2 2024 | -9.13% |
| Q1 2024 | -228.23% |
| Q4 2023 | 58.08% |
| Q3 2023 | -11.74% |
| Q2 2023 | 17.84% |
| Q1 2023 | 19.27% |
| Q4 2022 | -8.99% |
| Q3 2022 | -4.25% |
| Q2 2022 | -5.82% |
| Q1 2022 | -21.91% |
| Q4 2021 | -6.02% |
| Q3 2021 | 29.27% |
| Q2 2021 | 2.59% |
| Q1 2021 | 9.23% |
| Q4 2020 | -899.32% |
| Q3 2020 | 133.17% |
| Q2 2020 | 37.51% |
| Q1 2020 | 0.12% |
| Q4 2019 | -14.66% |
| Q3 2019 | 2.50% |
| Q2 2019 | -15.51% |
| Q1 2019 | -16.74% |
| Q4 2018 | -64.42% |
| Q3 2018 | 60.65% |
| Q2 2018 | -25.16% |
| Q1 2018 | 14.51% |
| Q4 2017 | -36.05% |
| Q3 2017 | -0.61% |
| Q2 2017 | 14.98% |
| Q1 2017 | 21.03% |
| Q4 2016 | -87.33% |
| Q3 2016 | -10.39% |
| Q2 2016 | -7.31% |
| Q1 2016 | -40.47% |